Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
1(33.3%)
Phase 2
1(33.3%)
Phase 4
1(33.3%)
3Total
Phase 1(1)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01047241Phase 2Completed

Nasal Administration of Sufentanil+Ketamine for Procedure-related Pain in Children

Role: lead

NCT00357942Phase 4Completed

Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy

Role: lead

NCT00347815Phase 1Unknown

Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers

Role: lead

All 3 trials loaded